ReviewRisk management and healthcare policy2024

Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus.

Zeyu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.